Clinical Trial Update: Nicotine and Cotinine Levels in Smokers With Schizophrenia and Schizoaffective Disorder - 2

View source ↗

Summary

This completed clinical trial evaluated nicotine and cotinine levels in smokers with schizophrenia and schizoaffective disorder. The trial was sponsored by the …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizoaffective Disorder
• Schizophrenia
• Tobacco Use Disorder

Drugs mentioned

• Nicotine (nicotine)

Snippet

Sponsor: National Institute on Drug Abuse (NIDA) | Conditions: Schizophrenia and Disorders With Psychotic Features, Tobacco Use Disorder | Status: COMPLETED